Ceftriaxone is administered intramuscularly in the office
The patient first receives structural MRI and functional MRI scans that are analyzed by the provider to identify and localize the personalized stimulation target in the patient's dorsolateral prefrontal cortex
METAOD005: A Phase IIb (randomized, double-blind, placebo-controlled) study to assess the efficacy (reduction in body weight), safety and tolerability of 12 weeks treatment with daily doses (1, 5, 10, 20 or 30 mg AOD9604) administered orally (capsules) in 300 healthy, clinically obese males, and females of non-child bearing potential, with a BMI 35 kg/m 2
AHK-Cu Investigations into Skin Cell Research Collagen production in skin cells tends to decline with age, leading to structural weakening and decreased elasticity
"Cognitive impairment and vitamin B12: a review"
Timing can make a difference